Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...

The patient was receiving mesalazine and 6-mercaptopurine and, 2 months before admission, had stopped a 4-month therapy course with the biologic agent adalimumab for treatment of Crohn's disease.

Biologics approved by the Food and Drug Administration (FDA) for managing ulcerative colitis include: Anti-TNF agents, such ...

The company will protect the branded anti-interleukin (IL)-12/23 biologic against sales erosion from pending biosimilars.

Currently available biologics have revolutionized the management ... idiopathic inflammatory arthritis of childhood. Etanercept, adalimumab and infliximab are the three TNF-α agents used.

have already reached £210 million for 2018/19 and it has asked trusts and CCGs not to sign any new agreements for Humira that last beyond 16 October, when the biologic loses patent protection.

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

Juvenile idiopathic arthritis is the most common chronic systemic disease associated with uveitis in childhood. Uveitis occurs in 11–22% of children with juvenile idiopathic arthritis.1 Due to the ...

AbbVie (ABBV) continues to dominate the adalimumab market with 72% share in the U.S., despite biosimilar threats gaining ground. Read more here.

Humira is a self-injectable treatment used for a number of autoimmune disorders. Biosimilars reference originator biologics such as Humira. To gain approval by the the Food and Drug Administration ...